Identification of JAML as an Immune-Associated Prognostic Marker in Non-Small Cell Lung Cancer
Lung Cancer: Targets and Therapy · 2026-09 · Volume 17 · 1-16
DOI: 10.2147/lctt.s616193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lung Cancer: Targets and Therapy, 2026-09. Verfasst von Qin Tian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shandong Provincial Third Hospital, Shandong University, Jinan, Shandong, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Shandong Provincial Third Hospital, Shandong University, Jinan, Shandong, People's Republic of China.
- Department of Gastroenterology, Shandong Second Provincial General Hospital, Jinan, Shandong, People's Republic of China.
- Department of Radiotherapy Oncology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People's Republic of China.
ORCID-Profile: Qin Tian
Zitieren
APA
Tian, Q., Zhang, F., & Han, C. (2026). Identification of JAML as an Immune-Associated Prognostic Marker in Non-Small Cell Lung Cancer. Lung Cancer: Targets and Therapy, Volume 17, 1-16. https://doi.org/10.2147/lctt.s616193
Vancouver
Tian Q, Zhang F, Han C. Identification of JAML as an Immune-Associated Prognostic Marker in Non-Small Cell Lung Cancer. Lung Cancer: Targets and Therapy. 2026;Volume 17:1-16. doi:10.2147/lctt.s616193
BibTeX
@article{Tian2026,
author = {Tian, Qin and Zhang, Fucheng and Han, Chunyan},
title = {Identification of JAML as an Immune-Associated Prognostic Marker in Non-Small Cell Lung Cancer},
journal = {Lung Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 17},
pages = {1--16},
doi = {10.2147/lctt.s616193}
}
EUVIMED